Swift Treatment using transcranial magnetic stimulation and Outcome Prediction in Depression - STOP-D

niversitätsklinikum der RWTH Aachen0 个研究点目标入组 44 人开始时间: 2022年2月4日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Adult wmen and women between 18 and 80 years-old with a current nonpsychotic depression (either as part of a major depressive disorder or bipolar disorder) according to ICD-10; at least 20 points on the 17-item Hamilton-scale at baseline; nonresponse to at least one antidepressant; stable psychiatric medication in the last two weeks; sufficient German language skills; written informed consent; in case of legal guardianship also informed consent of the legal guardian

•Known seizure disorder (epilepsia) or confounding neurological disease, dementia or cognitive impairment; other somatic disease that interfers with the investigation or has an effect on the investigated parameters; current alcohol or drug abuse Drogen-, Alkohol- oder Schmerzmittelabusus; pregnancy or lactation; electromagnetic or metallic medical devices in or connected to the body (e.g., pacemakers, drug pumps, cochlea implants); metal in the body (e.g., screws due to fractures, shards of metal, metal prostheses, non-MR-compatible vascular clips); previous heart and/or brain surgery; widespread tattoos; previous treatment with TMS

发起方

niversitätsklinikum der RWTH Aachen